...
Country | Date | Response |
---|---|---|
USA | 27OCT2020 | The proposal seems generally reasonable. A few value sets in NLM's Value Set Authority Center refer to Allergy to animal x dander (finding) concepts and will be directly affected if we do inactivation/creation rather than modification (which I can understand for editorial reasons). I am wondering whether procedure concepts also referring to "animal x dander" remain appropriate or would need to be refactored similarly to the corresponding Allergy concepts – they could be similarly genericized (e.g., Cat allergen specific immunoglobulin E antibody measurement). Just a thought. |
NL | 27OCT2020 | Agreed! |
IRL | 27/10/2020 | OK here, as these terms at not currently in use here. |
AUS |
| Just checking the evaluation procedures/observables will remain as these seem to be pretty standard across the industry.
There are also tests for urine, serum, epithelium individually and combinations of Otherwise, I think the change is reasonable for Clinical Findings. It's consistent to how 232350006|House dust mite allergy| is modelled. Presumably, this doesn't just apply to dander but all the 'animal materials', ie. feathers. Will this pattern also be extended to plants? pollens/seed Could just use even general substances like 'dog material substance' (Subtsance from dog) |
Member countries without a CMAG rep |
...